iHuman
6 hedge funds and large institutions have $7.46M invested in iHuman in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.12% less ownership
Funds ownership: 3% → 2.88% (-0.12%)
25% less funds holding
Funds holding: 8 → 6 (-2)
28% less capital invested
Capital invested by funds: $10.3M → $7.46M (-$2.86M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$5.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$150K |
| 2 |
Goldman Sachs
New York
|
-$129K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$11K |
| 4 |
Millennium Management
New York
|
-$7.82K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$6.46K |
IH Hedge Fund Activity: Q1 2022 in Review
6 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q1 2022, worth a combined $7.46M — down 28% from $10.3M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of IH and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was State Street, adding an estimated $5.98K. The largest seller was Morgan Stanley, cutting an estimated $150K.
- 6 institutional investors held iHuman (IH) as of Q1 2022, down from 8 in Q4 2021.
- Funds reported $7.46M of iHuman stock for Q1 2022, down 28% quarter-over-quarter.
- 0 funds opened new iHuman positions in Q1 2022 and 2 closed out, a net change of -2 holders.
- The largest iHuman buyer in Q1 2022 was State Street, an estimated $5.98K added.
- The largest iHuman seller in Q1 2022 was Morgan Stanley, an estimated $150K sold.
Based on aggregated 13F filings for Q1 2022.